AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GSK
  4. [6-K] GSK plc American Current Report (Foreign Issuer)

[6-K] GSK plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock GSK logo
GSK PLC

NYSE:GSK

GSK Rankings

#246 Ranked by Market Cap
#729 Ranked by Dividends

GSK Latest News

Jul 27, 2025
Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Jul 24, 2025
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
Jul 17, 2025
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
Jul 10, 2025
GSK begins shipping influenza vaccine doses for the 2025-26 flu season
Jun 24, 2025
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis

GSK Latest SEC Filings

Aug 11, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Aug 11, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Aug 8, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Aug 8, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)
Aug 7, 2025
[6-K] GSK plc American Current Report (Foreign Issuer)

GSK Stock Data

74.12B
2.04B
0.06%
18.29%
0.67%
Drug Manufacturers - General
Healthcare
United Kingdom
London